Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | RLAY | SLNO | ||
| Company | Enliven Therapeutics Inc | Relay Therapeutics Inc | Soleno Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 45.95 | 16.51 | 52.62 | ||
| High | 48.53 | 17.32 | 52.80 | ||
| Low | 45.53 | 16.16 | 52.59 | ||
| Latest | 48.11 | 16.76 | 52.78 | ||
| Change | +2.77 | +0.65 | +0.21 | ||
| % Change | +6.11% | +4.03% | +0.40% | ||
| Volume | 1,383,700 | 2,360,600 | 3,948,700 | ||
| 20-Day Average Volume | 1,702,170 | 3,465,310 | 7,046,455 | ||
| Previous Close | 45.34 | 16.11 | 52.57 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.95 | 12.49 | 42.80 | ||
| 20-Day Raw Stochastic | 97.89% | 93.05% | 99.91% | ||
| 20-Day Relative Strength | 72.94 | 78.30 | 71.34 | ||
| Weighted Alpha | +102.22 | +455.17 | -31.23 | ||
| Today's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.16% since 04/10/26 | +12.18% since 04/10/26 | +0.29% since 04/10/26 | ||
| Low | 42.56 on 04/15/26 | 14.32 on 04/15/26 | 52.51 on 04/13/26 | ||
| High | 48.53 on 04/17/26 | 17.32 on 04/17/26 | 52.80 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +73.12% since 03/17/26 | +63.35% since 03/17/26 | +56.99% since 03/17/26 | ||
| Low | 26.70 on 03/18/26 | 9.27 on 03/24/26 | 29.43 on 03/27/26 | ||
| High | 48.53 on 04/17/26 | 17.32 on 04/17/26 | 52.80 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +80.12% since 01/16/26 | +128.03% since 01/16/26 | +24.25% since 01/16/26 | ||
| Low | 24.90 on 01/29/26 | 7.01 on 01/20/26 | 29.43 on 03/27/26 | ||
| High | 48.53 on 04/17/26 | 17.32 on 04/17/26 | 52.80 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +124.71% since 10/17/25 | +158.24% since 10/17/25 | -19.38% since 10/17/25 | ||
| Low | 14.78 on 01/06/26 | 5.95 on 11/11/25 | 29.43 on 03/27/26 | ||
| High | 48.53 on 04/17/26 | 17.32 on 04/17/26 | 72.80 on 10/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,929,659 | 2,995,448 | 2,724,715 | ||
| Shares Outstanding, K | 60,895 | 178,726 | 51,624 | ||
| Annual Sales | 0 | 15,360,000 | 190,410,000 | ||
| Annual Net Income | -103,690,000 | -276,480,000 | 20,890,000 | ||
| Last Quarter Sales | 0 | 7,000,000 | 91,730,000 | ||
| Last Quarter Net Income | -29,670,000 | -54,890,000 | 43,360,000 | ||
| 60-Month Beta | 0.26 | 1.57 | -2.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 03/03/26 | -0.32 on 02/26/26 | 0.80 on 02/25/26 | ||
| Latest Earnings Date | 05/13/26 | 05/04/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 228.57 | ||